Skip to main content
. 2019 Aug 8;7:213. doi: 10.1186/s40425-019-0689-7

Table 2.

Comprehensive genomic profiling by FoundationOne™

Patient TMB Genomic Findings
4 15 muts/mb

CDKN2A/B loss

CHEK2 R117G

DNMT3A R771

FANCD2 E118

MLL3 splice site 2533-1G > A

TP53 L145R, splice site 673-1G > A

5 12 muts/mb

CRKL amplification

DNMT3A R635W – subclonal

MAPK1 amplification

SF3B1 K700E – subclonal

ZRSR2 splice site 121 + 2 T > G